Jeffrey Arnold

John Arnold

Mr. Arnold is the president of Arnold Strategies, LLC, which helps business owners and entrepreneurs grow their businesses and achieve their goals. Clients have included companies in consumer products, digital media, advertising, manufacturing, medical devices, e-commerce, services and biotech.

From 2001 to 2005 Mr. Arnold was CEO of CardioFocus where he developed a unique endoscopic catheter for treating atrial fibrillation - now in human trials. Prior to that he founded Cambridge Heart, Inc. (NASDAQ: CAMH), a supplier of cardiology diagnostic equipment, which he took public in 1996. Prior to that he was CEO of Molecular Simulations, Inc., a $100 MM supplier of software for drug design now called Accelrys (NASDAQ: ACCL). In his early career Mr. Arnold held senior R&D and marketing positions for Becton Dickinson and ran the instrumentation group for medical equipment supplier Datascope Corp.

Mr. Arnold is a guest lecturer at the MIT Entrepreneurship Center and Sloan School, a mentor to early stage companies through the MIT Venture Mentoring Society, an overseer at the Museum of Science and is on the grant review board at the MIT Deshpande Center. He was formerly Chairman of the Board of the Greater Boston Chapter of the American Heart Association. He received a BSEE from MIT.